In Week of Mar 28, 2026, Unihealth Hospitals Ltd (Hospitals/Medical Services) is outperforming Nifty 500 with +51.9% relative strength. Fundamentals: Strong. On a 4-week streak.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Based on H1 FY26 earnings • Updated Mar 7, 2026
What: New hospitals in Navi Mumbai and Nashik targeting ₹1 crore revenue per bed annually
Impact: +₹25 Cr revenue
“Management stated: 'Going forward, in the coming 24 months, we intend and are committed to replicating the same success across the upcoming UMC Hospitals network in India'”
What: Potential 100% acquisition of mature facility operating at 35%+ EBITDA margin
Impact: +₹20 Cr revenue
“Management stated: 'If at all the management does decide to take that step forward... profit after tax for the company is likely to increase significantly'”
Earnings deceleration risks from management commentary
Trigger: Continued currency depreciation
Impact: -500 bps margin impact
Management view: Focusing on Uganda as stable market with INR30,000+ per occupied bed while Nigeria faced challenges
Monitor: Africa revenue per bed in INR
Trigger: Debtors continue increasing
Impact: -300 bps margin impact
Management view: Debtors will start coming down from second half of this financial year
Monitor: Debtor days
Key quotes from recent conference calls
“Going forward, in the coming 24 months, we intend and are committed to replicating the same success across the upcoming UMC Hospitals network in India, bringing together the benefits be of an existing mature business of the company in Africa with the highly scalable opportunities in a stable and rapidly growing market like India. — Management”
“We sustained an EBITDA margin of 36.5%, and net profit margin reached 25.92%. EPS for the year stood at INR9.83 compared to INR7.67 last year. — Management”
“Going forward, as we expand in India and in East Africa as well, though the absolute numbers from Uganda are likely to increase significantly, since that is a mature business for us now, the total top line contribution from that facility within the next 24 months is being aimed at less than one third of the total consolidated revenue. — Akshay Parmar”
“We will be targeting somewhere around INR1 crores in terms of the revenue per occupied bed, translating to say about INR27,500, INR28,000 per day. This is the first target. — Akshay Parmar”
Forward-looking targets from management for 24 months
Implied PAT Growth
30%
Capex Plan
₹10.5 Cr
Key Milestones
• 350-400 operational beds by FY26
• Africa revenue <33% of total within 24 months
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +56% | +15% | Stable |
| PAT (Net Profit) | +222% | +55% | Stable |
| OPM | 48.0% | +1300 bps | Volatile |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Mar 7, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Unihealth Hospitals Ltd's latest quarterly results (Sep 2025) show
Unihealth Hospitals Ltd's profit is growing with an stable trend.
Unihealth Hospitals Ltd's revenue growth trend is stable.
Unihealth Hospitals Ltd's operating margin is volatile.
Unihealth Hospitals Ltd's long-term compounding rates
Unihealth Hospitals Ltd's earnings growth is stable with positive momentum on a sequential basis.
Unihealth Hospitals Ltd appears significantly undervalued based on our fair value analysis.
Unihealth Hospitals Ltd's current PE ratio is 24.8x.
Unihealth Hospitals Ltd's current PE is 24.8x.
Unihealth Hospitals Ltd's price-to-book ratio is 4.7x.
Unihealth Hospitals Ltd is rated Strong with a fundamental score of 65/100. This score is calculated from objective financial metrics
Unihealth Hospitals Ltd has a debt-to-equity ratio of N/A.
Unihealth Hospitals Ltd's return ratios over recent years
Unihealth Hospitals Ltd's operating cash flow is negative (FY2025).
Unihealth Hospitals Ltd currently does not pay a significant dividend (yield 0.00%).
Unihealth Hospitals Ltd's shareholding pattern (Sep 2025)
Unihealth Hospitals Ltd's promoter holding has increased recently.
Unihealth Hospitals Ltd has been outperforming Nifty 500 for 4 consecutive weeks, indicating building momentum.
Unihealth Hospitals Ltd is an established outperformer with 4 weeks of consecutive Nifty 500 outperformance.
Unihealth Hospitals Ltd has 2 key growth catalysts identified from recent earnings analysis
Unihealth Hospitals Ltd has 2 key risks worth monitoring
In H1 FY26, Unihealth Hospitals Ltd's management highlighted
Unihealth Hospitals Ltd's management has provided the following forward guidance for 24 months
Based on quantitative research signals, here is why Unihealth Hospitals Ltd may be worth studying
Unihealth Hospitals Ltd investment thesis summary:
Unihealth Hospitals Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
